A Comparison of Different Valgancyclovir Formulations in the Universal 6-Month Prophylaxis Against CMV Infection in Renal Transplant Recipients: A Randomized Single-Centre Study

1. De Keyzer K, Van Laecke S, Peeters P, Vanholder R. Human cytomegalovirus and kidney transplantation: a clinician’s update. Am J Kidney Dis. 2011; 58(1): 118–126.10.1053/j.ajkd.2011.04.010Search in Google Scholar

2. Freeman RB., Jr. The ‘indirect’ effects of cytomegalovirus infection. Am J Transplant. 2009; 9: 2453–2458.10.1111/j.1600-6143.2009.02824.xSearch in Google Scholar

3. Hodson EM, Ladhani M, Webster AC, Strippoli GF, Craig JC. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev. 2013: CD003774.10.1002/14651858.CD003774.pub4Search in Google Scholar

4. Humar A, Lebranchu Y, Vincenti F, et al. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant. 2010; 10: 1228–1237.10.1111/j.1600-6143.2010.03074.xSearch in Google Scholar

5. Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM. Expanded criteria donors for kidney transplantation. Am J Transplant. 2003; 3 Suppl 4: 114–125.10.1034/j.1600-6143.3.s4.11.xSearch in Google Scholar

6. Selvey LA, Lim WH, Boan P, et al. Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience. BMC Infect Dis 2017; 17(1): 501.10.1186/s12879-017-2599-ySearch in Google Scholar

7. Florescu DF, Qiu F, Schmidt CM, Kalil AC. A direct and indirect comparison meta-analysis on the efficacy of cytomegalovirus preventive strategies in solid organ transplant. Clin Infect Dis. 2014 Mar; 58(6): 785–803.10.1093/cid/cit945Search in Google Scholar

8. Harvala H, Stewart C, Muller K, Burns S, Marson L, MacGilchrist A, Johannessen I. High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy. J Med Virol. 2013; 85(5): 893–898.10.1002/jmv.23539Search in Google Scholar

9. Razonable RR, Hayden RT. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation. Clin Microbiol Rev. 2013; 26: 703–727.10.1128/CMR.00015-13Search in Google Scholar

10. Martin-Gandul C, Perez-Romero P, Sanchez M, et al. Spanish network for research in infectious D: determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection. J Clin Virol. 2013; 56: 13–18.10.1016/j.jcv.2012.09.017Search in Google Scholar

11. Razonable RR, Humar A. Cytomegalovirus in solid organ transplantation. Am J Transplant. 2013; 13: 93–106.10.1111/ajt.12103Search in Google Scholar

12. Torre-Cisneros J, Aguado JM, Caston JJ et al. Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. Transplant Rev (Orlando) 2016; 30: 119–143.10.1016/j.trre.2016.04.001Search in Google Scholar

13. Halimi JM. Low-grade proteinuria and microalbuminuria in renal transplantation. Transplantation. 2013; 96(2): 121–130.10.1097/TP.0b013e31828719fbSearch in Google Scholar

14. Ponticelli C, Graziani G. Proteinuria after kidney transplantation. Transpl Int. 2012; 25(9): 909–917.10.1111/j.1432-2277.2012.01500.xSearch in Google Scholar

15. Liang X, Famure O, Li Y, Kim SJ. Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis. Prog Transplant. 2018; 28(2): 124–133.10.1177/1526924818765798Search in Google Scholar

16. Tedesco-Silva H, Pascual J, Viklicky O, et al. Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study. Transplantation. 2019 Feb 19.10.1097/TP.0000000000002626Search in Google Scholar

17. Vilibic-Cavlek T, Kolaric B, Bogdanic M, Tabain I, Beader N. Herpes Group Viruses: a Seroprevalence Study in Hemodialysis Patients. Acta Clin Croat. 2017; 56(2): 255–261.10.20471/acc.2017.56.02.08Search in Google Scholar